Oral therapy IFB-088 (icerguastat) was safe and significantly slowed disease progression in certain people with amyotrophic lateral sclerosis (ALS), according to new data from a Phase 2 clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback